The global proteomics market is projected to reach $109.71 billion by 2034 from $33.92 billion in 2024, growing at a CAGR of 12.46% during the forecast period 2024-2034.
The global electrophysiology market is projected to reach $32.79 billion by 2034 from $9.77 billion in 2024, growing at a CAGR of 12.88% during the forecast period 2024-2034.
The global cochlear implants market is projected to reach $6,639.9 million by 2034 from $2,800.2 million in 2024, growing at a CAGR of 9.02% during the forecast period 2024-2034.
The global spatial genomics and transcriptomics market is projected to reach $2,158.6 million by 2034 from $662.3 million in 2024, growing at a CAGR of 12.54% during the forecast period 2024-2034.
The global multi-cancer early detection market is projected to reach $5,153.5 million by 2034 from $1,138.3 million in 2024, growing at a CAGR of 16.30% during the forecast period 2024-2034.
Need reports on an on-going basis? Do consider our annual subscription
The global dental implants market is projected to reach $8.63 billion by 2034 from $4.73 billion in 2024, growing at a CAGR of 6.20% during the forecast period 2024-2034.
The U.S. AI in healthcare market is projected to reach $229.70 billion by 2034 from $7.71 billion in 2024, growing at a CAGR of 40.41% during the forecast period 2024-2034.
The global precision medicine market is projected to reach $469.16 billion by 2034 from $151.57 billion in 2024, at a CAGR of 11.96% during the forecast period of 2024-2034.
The Latin America NGS market was valued at $268.04 million in 2024 and is anticipated to reach $597.20 million by 2034, witnessing a CAGR of 8.34% during the forecast period 2024-2034.
The Central America ultrasound systems market was valued at $23.9 million in 2021 and is anticipated to grow to $43.1 million by the end of 2031, at a projected CAGR of 6.07% during the forecast period 2022-2031.
The global spinal navigation market was valued at $606.6 million in 2022 and is anticipated to reach $2,683.9 million by the end of 2032, at a CAGR of 16.09% during the forecast period 2023-2032.
The report is focused on an overview of MRD testing in U.S., profiles of MRD testing facilities, market size, 2020-2030, technology landscape and key dynamics of the market.
The South Korea flow cytometry market was valued at $82.12 million in 2024 and is projected to reach $244.49 million by 2033, growing at a CAGR of 12.89% during the forecast period (2024-2033).
The global in silico CROs market was valued at $2.25 billion in 2022 and is projected to reach $12.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 19.06%.
The ultrasound market in Brazil was valued at $118.5 million in 2022 and is anticipated to grow to $209.2 million by the end of 2030, at a projected CAGR of 7.49% during the forecast period 2023-2030.
The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033.
The Europe genome sequencing market was valued at $2.22 billion in 2024 and is expected to reach $7.23 billion by 2033, growing at a CAGR of 14.04% between 2024 and 2033.
The U.S. breast cancer screening and diagnostic market was valued at $1,556.6 million in 2024 and is anticipated to reach $2,342.2 million by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-2030.
The global urinary bag market was valued at $649.0 million in 2023 and is anticipated to grow to $976.8 million by the end of 2033, at a projected CAGR of 4.17% during the forecast period 2024-2033.
The Asia-Pacific cell and gene therapy manufacturing QC market was valued at $246.4 million in 2023 and is anticipated to reach $1,317.3 million by 2033, witnessing a CAGR of 18.36% during the forecast period 2024-2033.
The Australia NIPT market was valued at $40.0 million in 2023 and is expected to reach $110.7 million by 2033, registering a CAGR of 10.71% during the forecast period 2024-2033.
The Europe robotic surgery consumables market was valued at $848.5 million in 2023 and is expected to reach $2,856.4 million by 2033, growing at a CAGR of 12.91% during the forecast period 2023-2033.
The Asia-Pacific robotic surgery consumables market was valued at $654.3 million in 2023 and is expected to reach $2,293.1 million by 2033, growing at a CAGR of 13.36% during the forecast period 2023-2033.
The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033.
The Asia-Pacific Targeted Sequencing Market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033.
The Europe precision medicine software market was valued at $416.1 million in 2023 and is expected to reach $1,224.7 million by 2033, growing at a CAGR of 11.47% between 2024 and 2033.
The Europe Microarray Analysis Market was valued at $1,690.2 million in 2023 and is expected to reach $3,236.0 million by 2033, growing at a CAGR of 6.71% during the forecast period 2023-2033.
The global protein sequencing market is projected to reach $2,697.0 million by 2033 from $1,749.0 million in 2023, growing at a CAGR of 4.36% during the forecast period 2024-2033.
The Europe aseptic connectors market was valued at $198.8 million in 2023 and is expected to reach $472.9 million by 2033, growing at a CAGR of 9.05% between 2023 and 2033.
The Asia-Pacific metagenomics market was valued at $376.1 million in 2023 and is expected to reach $2,238.0 million by 2033, growing at a CAGR of 19.65% between 2024 and 2033.
The global digital PCR (d-PCR) market is projected to reach $3,351.0 million by 2034 from $678.1 million in 2023, growing at a CAGR of 15.75% during the forecast period 2024-2034.
The Europe companion diagnostics market was valued at $1,116.5 million in 2023 and is expected to reach $3,562.1 million by 2033, growing at a CAGR of 12.30% between 2023 and 2033.
The Europe HPLC market was estimated at $1,269.2 million in 2023 and is expected to reach $2,014.3 million by 2033, growing at a CAGR of 4.73% during the forecast period 2023-2033.
The Asia-Pacific digital diagnostics market is projected to reach $2,029.9 million by 2033 from $314.7 million in 2023, growing at a CAGR of 20.49% during the forecast period 2023-2033.
The Europe dental infections control market is projected to reach $758.3 million by 2033 from $390.3 million in 2023, growing at a CAGR of 6.87% during the forecast period 2023-2033.
The Asia-Pacific DNA methylation detection technology market was valued at $443.6 million in 2023 and is expected to reach $2,280.6 million by 2033, growing at a CAGR of 17.79% between 2023 and 2033.
The global whole genome and exome sequencing market is projected to reach $7,467.6 million by 2033 from $1,873.8 million in 2023, growing at a CAGR of 15.13% during the forecast period 2024-2033.
The Asia-Pacific Automated Sample Preparation Market was valued at $317.5 million in 2023 and is expected to reach $969.6 million by 2033, growing at a CAGR of 11.81% between 2023 and 2033.
The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033.
The Europe digital surgery technologies market is projected to reach $3,769.2 million by 2033 from $215.7 million in 2023, growing at a CAGR of 33.12% during the forecast period 2023-2033.
The Europe automated sample preparation market was valued at $381.3 million in 2023 and is expected to reach $925.1 million by 2033, growing at a CAGR of 9.27% between 2023 and 2033.
In an optimistic scenario, the market, valued at $8.7 million in 2024, is anticipated to grow at a CAGR of 15.43%, reaching $36.7 million by 2034.
The Asia-Pacific protein expression market was valued at $530.6 million in 2023 and is expected to reach $1,809.8 million by 2033, growing at a CAGR of 13.05% between 2023 and 2033.
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% during the forecast period 2024-2033.
The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033.
The global hematologic malignancies testing market was valued at $3,546.3 million in 2023 and is expected to reach $13,509.5 million by 2033, growing at a CAGR of 14.09% during the forecast period 2024-2033.
The global liquid biopsy market was valued at $4,072.6 million in 2023 and is expected to reach $20,224.7 million by 2033, growing at a CAGR of 16.83% during the forecast period 2024-2033.
The global hereditary genetic testing market is projected to reach $81.95 billion by 2033 from $24.78 billion in 2023, growing at a CAGR of 12.73% during the forecast period 2024-2033.
The Asia-Pacific synthetic hormones market size was estimated at $2.41 billion in 2023 and is expected to reach $4.89 billion by 2033, growing at a CAGR of 7.34% during the forecast period 2023-2033.
The Asia-Pacific dental infections control market is projected to reach $627.7 million by 2033 from $300.5 million in 2023, growing at a CAGR of 7.64% during the forecast period 2023-2033.
The global metagenomics market was valued at $1,808.0 million in 2023 and is expected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% between 2024 and 2033.
The global surgical robotics simulation market was valued at $427.9 million in 2023 and is expected to reach $2,132.3 million by 2033, growing at a CAGR of 17.31% between the forecast period of 2024-2033.
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033.
The global genome sequencing market was valued at $7.56 billion in 2023 and is expected to reach $30.23 billion by 2033, growing at a CAGR of 15.18% between 2024 and 2033.
The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033.
The Europe digital therapeutics market is projected to reach $13.91 billion by 2033 from $1.68 billion in 2023, growing at a CAGR of 23.54% during the forecast period 2023-2033.
Expected to grow from a base of $1.02 billion in 2024, the market is projected to experience a compound annual growth rate (CAGR) of 8.43%, reaching approximately $2.29 billion by 2034.
The global advanced wound dressing market is projected to reach $8,383.1 million by 2030 from $6,418.5 million in 2023, growing at a CAGR of 3.89% during the forecast period 2023-2030.
The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023.
The global non-silicone foam dressings market is projected to reach $699.7 million by 2030 from $529.4 million in 2023, growing at a CAGR of 4.07% during the forecast period 2023-2030.
The global non-silver antimicrobial dressings market is projected to reach $565.8 million by 2030 from $437.2 million in 2023, growing at a CAGR of 3.75% during the forecast period 2023-2030.
The global organ-on-chip market is projected to reach $3,596.3 million by 2033 from $109.9 million in 2023, growing at a CAGR of 42.09% during the forecast period 2024-2033.
The Europe interventional imaging market is projected to reach $4.23 billion by 2033 from $2.23 billion in 2023, growing at a CAGR of 6.62% during the forecast period 2023-2033.
The global wound therapy devices market is projected to reach $6,473.5 million by 2030 from $4,781.7 million in 2023, growing at a CAGR of 4.42% during the forecast period 2023-2030.
The global wound skin substitutes market is projected to reach $2,062.6 million by 2030 from $1,255.5 million in 2023, growing at a CAGR of 7.35% during the forecast period 2023-2030.
The global PMS and menstrual health supplements market was valued at $21.68 billion in 2023 and is expected to reach $37.23 billion by 2033, growing at a CAGR of 5.45% between 2023 and 2033.
The global medical tape and bandages market is projected to reach $4,490.8 million by 2030 from $3,750.5 million in 2023, growing at a CAGR of 2.61% during the forecast period 2023-2030.
The global silicone scar dressing market is projected to reach $495.6 million by 2030 from $318.9 million in 2023, growing at a CAGR of 6.50% during the forecast period 2023-2030.
The Europe MRD testing market is projected to reach $1,744.0 million by 2033 from $424.0 million in 2023, growing at a CAGR of 15.19% during the forecast period 2023-2033.
The global dental implants and prosthetics market has been valued at $11.44 billion in 2024 and is expected to grow at a CAGR of 7.09% to reach $22.70 billion by 2034
The global surgical/sharp debridement market was valued at $209.7 million in 2023 and is anticipated to reach $295.9 million by 2030, witnessing a CAGR of 5.05% during the forecast period 2023-2030.
The global wound electrical stimulation devices market was valued at $207.5 million in 2023 and is anticipated to reach $328.4 million by 2030, witnessing a CAGR of 6.78% during the forecast period 2023-2030.
Considering the optimistic scenario, the global medical robots market has been valued at $16.39 billion in 2024 and is expected to grow at a CAGR of 18.31%.
The global wound biologics market was valued at $1,974.7 million in 2023 and is anticipated to reach $3,321.5 million by 2030, witnessing a CAGR of 7.71% during the forecast period 2023-2030.
The global hyperbaric oxygen therapy market was valued at $480.0 million in 2023 and is anticipated to reach $734.1 million by 2030, witnessing a CAGR of 6.26% during the forecast period 2023-2030.
The global silver antimicrobial dressings market was valued at $1,014.0 million in 2023 and is anticipated to reach $1,256.3 million by 2030, witnessing a CAGR of 3.11% during the forecast period 2023-2030.
The global enzymatic debridement market was valued at $553.2 million in 2023 and is anticipated to reach $826.1 million by 2030, witnessing a CAGR of 5.90% during the forecast period 2023-2030.
The global hydrocolloid dressings market was valued at $816.6 million in 2023 and is anticipated to reach $1,029.9 million by 2030, witnessing a CAGR of 3.37% during the forecast period 2023-2030.
The global silicone foam dressings market was valued at $1,263.4 million in 2023 and is anticipated to reach $1,731.2 million by 2030, witnessing a CAGR of 4.60% during the forecast period 2023-2030.
The global offloading devices market was valued at $1,207.5 million in 2023 and is anticipated to reach $1,546.6 million by 2030, witnessing a CAGR of 3.60% during the forecast period 2023-2030.
The global compression bandages market was valued at $769.4 million in 2023 and is anticipated to reach $1,019.3 million by 2030, witnessing a CAGR of 4.10% during the forecast period 2023-2030.
The Europe DNA/RNA sample extraction and isolation market was valued at $629.0 million in 2023 and is expected to reach $1,236.2 million by 2033, growing at a CAGR of 6.99% between 2023 and 2033.
The global mechanical debridement market was valued at $363.6 million in 2023 and is anticipated to reach $536.0 million by 2030, witnessing a CAGR of 5.70% during the forecast period 2023-2030.
The global wound growth factors market was valued at $421.7 million in 2023 and is anticipated to reach $750.7 million by 2030, witnessing a CAGR of 8.59% during the forecast period 2023-2030.
The global hydrogel dressings market was valued at $191.7 million in 2023 and is anticipated to reach $260.0 million by 2030, witnessing a CAGR of 4.45% during the forecast period 2023-2030.
The global negative pressure wound therapy (NPWT) market was valued at $2,117.3 million in 2023 and is anticipated to reach $2,845.1 million by 2030, witnessing a CAGR of 4.31% during the forecast period 2023-2030.
The global ultrasonic debridement market was valued at $145.6 million in 2023 and is anticipated to reach $240.6 million by 2030, witnessing a CAGR of 7.43% during the forecast period 2023-2030.
The global contact layer dressings market was valued at $557.2 million in 2023 and is anticipated to reach $712.6 million by 2030, witnessing a CAGR of 3.58% during the forecast period 2023-2030.
The global alginate dressings market was valued at $393.1 million in 2023 and is anticipated to reach $519.8 million by 2030, witnessing a CAGR of 4.07% during the forecast period 2023-2030.
The global collagen dressings market was valued at $477.2 million in 2023 and is anticipated to reach $613.1 million by 2030, witnessing a CAGR of 3.65% during the forecast period 2023-2030.
The global film dressings market was valued at $525.9 million in 2023 and is anticipated to reach $695.9 million by 2030, witnessing a CAGR of 4.08% during the forecast period 2023-2030.
The global superabsorbent dressings market was valued at $212.8 million in 2023 and is anticipated to reach $298.8 million by 2030, witnessing a CAGR of 4.97% during the forecast period 2023-2030.
The Europe scar management market was valued at $238.5 million in 2023 and is anticipated to reach $351.0 million by 2030, witnessing a CAGR of 5.67% during the forecast period 2023-2030.
The Asia-Pacific wearable patches market was valued at $2,268.6 million in 2023 and is expected to reach $5,300.6 million by 2031, growing at a CAGR of 11.19% between 2023 and 2031.
The global robotic surgery consumables market was valued at $4.87 billion in 2023 and is expected to reach $15.61 billion by 2033, growing at a CAGR of 12.34% during the forecast period 2023-2033.
The global targeted sequencing market was valued at $3,479.8 million in 2023 and is expected to reach $10,987.4 million by 2033, growing at a CAGR of 12.28% between 2024 and 2033.
The global computed tomography market is projected to reach $10.21 billion by 2033 from $6.17 billion in 2023, growing at a CAGR of 5.22% during the forecast period 2024-2033.
The global precision medicine software market was valued at $1,824.9 million in 2023 and is expected to reach $5,696.3 million by 2033, growing at a CAGR of 12.13% between 2024 and 2033.
The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033.
The global wound debridement market was valued at $1,272.0 million in 2023 and is expected to reach $1,898.6 million by 2030, growing at a CAGR of 5.89% during the forecast period 2023-2030.
The global microarray analysis market was valued at $5,357.9 million in 2023 and is expected to reach $10,112.4 million by 2033, growing at a CAGR of 6.56% during the forecast period 2023-2033.
The global companion diagnostics market was valued at $3,762.0 million in 2023 and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033.
The global HPLC market was estimated at $5.23 billion in 2023 and is expected to reach $8.22 billion by 2033, growing at a CAGR of 4.61% during the forecast period 2023-2033.
The global aseptic connectors market was valued at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033.
The Europe wound cleanser market was valued at $460.7 million in 2023 and is expected to reach $564.8 million by 2030, growing at a CAGR of 2.95% between 2023 and 2030.
The Europe rare disease genetic testing market was valued at $1.16 billion in 2023 and is anticipated to reach $4.17 billion by 2033, witnessing a CAGR of 13.60% during the forecast period 2023-2033.
The global colorectal cancer screening and diagnostics market was valued at $38,540.7 million in 2023 and is expected to reach $48,710.9 million by 2033, growing at a CAGR of 2.37% during the forecast period 2023-2033.
The global nucleic acid sample preparation market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033.
The MRD testing market was valued at $1.47 billion in 2022 and is expected to reach $6.67 billion by 2033, growing at a CAGR of 14.81% between 2023 and 2033.
The global digital diagnostics market is projected to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast period 2023-2033.
The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033.
The Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market is projected to reach $1,779.4 Million by 2032 from $554.3 Million in 2023, growing at a CAGR of 13.84% during the forecast period 2023-2032.
In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033.
The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026.
The global automated sample preparation market was valued at $1,431.9 million in 2023 and is expected to reach $3,730.5 million by 2033, growing at a CAGR of 10.05% between 2023 and 2033.
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033.
The Europe cell and gene therapy manufacturing Quality Control (QC) market is expected to reach $2,545.6 million by 2033 from $534.3 million in 2023 at a CAGR of 16.90% during the forecast period 2023-2033.
The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033.
The global continuous bioprocessing market was valued at $250.1 million in 2023 and is expected to reach $1,639.1 million by 2033, growing at a CAGR of 20.68% between 2023 and 2033.
In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033.
The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033.
The Europe nucleic acid therapeutics CDMO market was valued at $1.27 billion in 2023 and is expected to reach $3.88 billion by 2033, growing at a CAGR of 11.80% during the forecast period 2023-2033.
The Asia-Pacific gene editing technologies market was valued at $0.49 billion in 2023 and is anticipated to reach $5.05 billion by 2032, witnessing a CAGR of 29.64% during the forecast period 2023-2032.
The global DNA methylation detection technology market was valued at $2.80 billion in 2023 and is expected to reach $12.32 billion by 2033, growing at a CAGR of 15.96% between 2023 and 2033.
The Asia-Pacific cell-based assay market was valued at $4.05 billion in 2023 and is anticipated to reach $9.19 billion by 2032, witnessing a CAGR of 9.53% during the forecast period 2023-2032.
The Europe multicancer screening market is projected to reach $2.09 billion by 2032 from $0.55 billion in 2023, growing at a CAGR of 15.93% during the forecast period 2023-2032.
The global protein expression market was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033.
The market size was estimated at $19.40 billion in 2023 and is expected to reach $38.08 billion by 2033, growing at a CAGR of 6.98% during the forecast period 2023-2033.
The global dental infections control market is projected to reach $2,445.4 million by 2033 from $1,292.4 million in 2023, growing at a CAGR of 6.59% during the forecast period 2023-2033.
The global clinical biomarkers market was valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033.
The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033.
The Europe gene fusion testing market was valued at $71.4 million in 2023 and is anticipated to reach $248.2 million by 2033, witnessing a CAGR of 13.27% during the forecast period 2023-2033.
The market size is anticipated to be $0.06 billion in 2026 and is expected to reach $7.72 billion by 2040, growing at a CAGR of 41.55% during the forecast period 2026-2040.
The Korea centrifugation market was valued at $46.1 million in 2023 and is expected to reach $80.6 million by 2033, growing at a CAGR of 5.75% between 2023 and 2033.
The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.
The Asia-Pacific NGS data storage market is projected to reach $1,284.3 million by 2033 from $207.5 million in 2023, growing at a CAGR of 19.99% during the forecast period 2023-2033.
The global veterinary vaccine market is projected to reach $19.86 billion by 2033 from $9.82 billion in 2023, growing at a CAGR of 7.30% during the forecast period 2023-2033.
The Europe artificial intelligence/machine learning medical device market was valued at $1.01 billion in 2022 and is expected to reach $7.93 billion by 2032, witnessing a CAGR of 22.95% during the forecast period 2022-2032.
The Europe minimally invasive spine technologies market was valued at $691.1 million in 2022 and is anticipated to reach $2,116.5 million by 2032, witnessing a CAGR of 11.84% during the forecast period 2022-2032.
The Europe autonomous surgical robotics market was valued at $432.7 million in 2023 and is expected to reach $2,157.0 million by the end of 2033.
As of 2023, the Europe genomic cancer panel and profiling market was valued at $2.64 billion and is expected to attain a value of $6.50 billion in 2033.
The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033.
The sleep apnea oral appliances market report presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
This report aims to provide a comprehensive analysis of the single use assemblies market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global healthcare cloud computing market report provides a comprehensive analysis of the current trends, market size, growth drivers, and challenges in the healthcare cloud computing industry.
The global elderly care services market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Asia-Pacific Advanced Dental Digital and Robotics Solutions Market: Analysis and Forecast, 2023-2032
In 2023, the Asia-Pacific advanced dental digital and robotics solutions market was valued at $0.8 billion and is expected to reach $2.1 billion by 2032.
The global bioprocess bags and containers market report offers a detailed assessment of market segments, including product type and end user, elucidating their respective market shares and growth prospects.
The bioprocessing probes and sensors market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report delves into various factors influencing the industry, including recent trends, recent advancements, and regulatory aspects.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the veterinary equipment and supplies sector.
The Asia-Pacific rare disease genetic testing market was valued at $0.51 billion in 2022 and is expected to reach $2.40 billion by 2033, witnessing a CAGR of 15.25% during the forecast period 2023-2033.
The Europe acute care syndromic testing market was valued at $0.90 billion in 2022 and is expected to reach $2.32 billion by 2033, growing at a CAGR of 8.95% between 2023 and 2033.
The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032.
The Europe EV-based liquid biopsy market was valued at $18.88 million in 2022 and is anticipated to reach $115.34 million by 2032.
The global pen needle market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report offer a comprehensive overview of the microcarriers market, highlighting key trends, growth drivers, challenges, and opportunities shaping this dynamic industry.
The report contains crucial statistics concerning the status of prominent players in the cystatin C assay market, highlighting key trends and potential opportunities within the market.
The Asia-Pacific wound cleanser market was valued at $547.4 million in 2022 and is expected to reach $754.6 million by 2030, growing at a CAGR of 4.10% during the forecast period 2023-2030.
The Asia-Pacific laboratory automation market was valued at $1.17 billion in 2022 and is expected to reach $3.69 billion by the end of 2033, registering a CAGR of 11.03% during the forecast period 2023-2033.
The remote patient monitoring (RPM) market report provides a comprehensive analysis of the global market for remote patient monitoring technologies and services.
The immunoassay plays a pivotal role in diagnostics and therapeutic applications, encompassing a wide range of techniques such as ELISA, western blotting, radioimmunoassay, and rapid tests.
The Europe wearable patches market was valued at $3.03 billion in 2022 and is expected to reach $7.85 billion by 2031, growing at a CAGR of 10.29% between 2023 and 2031.
The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033.
The hemostats market report provides a comprehensive analysis of presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
The global fetal and neonatal care equipment market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Global Restorative Dentistry Market rising prevalence of oral health diseases, a heightened emphasis on aesthetics, and the growing trend of dental tourism in emerging markets.
The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge.
The MEA cosmeceuticals market is experiencing robust growth due to several key factors. Firstly, there is a rising awareness and demand for skincare and beauty products among the population in the region.
The global antibody therapeutic market occupies a pivotal role within the biopharmaceutical and life sciences sectors, dedicated to the manufacturing, advancement, and commercialization of antibodies with diverse applications in medical and research domains.
This report aims to provide a comprehensive analysis of the ALL market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global tympanometer market research report offers a detailed insight into the market, providing an in-depth analysis of the market's current prospects.
The global CRRT market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the bariatric surgery sector.
Global bioprocessing validation market report serves as a valuable resource for industry participants, investors, and decision-makers seeking to navigate the dynamic landscape.
ELISpot and FluoroSpot Assay Market play a crucial role in immunological research and diagnostics, and this report projects the market landscape on a global scale.
The respiratory diagnostics market is a rapidly growing focused on the diagnosis and monitoring of various respiratory conditions.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The global market for urological devices plays a crucial role in diagnosing and treating a diverse range of urological conditions, including urolithiasis, urethral malignancies, bladder disorders, and kidney diseases.
The report constitutes an extensive study of GCC Veterinary Laboratories industry.
This comprehensive report offers an in-depth analysis of the Global Surgical Sutures Market, covering key trends, market dynamics, competitive landscape, and future projections.
The global pharmaceutical excipients market is witnessing robust growth due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The market's expansion is driven by factors such as increasing incidence of cancer, continuous technological advancements such as the development of MRI linear accelerators, proton therapy, and the introduction of treatment planning software that integrates with imaging data.
The transdermal patches market encompasses a dynamic sector within the pharmaceutical industry that focuses on the development, manufacturing, and distribution of patches designed for drug delivery through the skin.
Digital health refers to the integration of digital technologies, such as software, mobile devices, telemedicine, wearable sensors, artificial intelligence (AI), and other technological tools, into healthcare and medicine.
The global genomic cancer panel and profiling market is expected to reach $26.59 billion by 2033 from $9.90 billion in 2022.
The report highlights the transformative impact of biologic therapies on individuals suffering from chronic inflammatory diseases, showcasing how these treatments have not only reduced dependency on health and welfare systems but also improved patients' physical function, enabling them to live more independently.
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032.
The global autonomous surgical robotics market was valued at $1.81 billion in 2022 and is anticipated to reach $11.07 billion by 2033.
As of 2022, the Asia-Pacific multicancer screening market was valued at $0.27 billion and is expected to attain a value of $1.40 billion by 2032.
The Asia-Pacific medical X-Ray detectors market was valued at $508.2 million in 2022 and is anticipated to grow to $913.7 million by the end of 2032.
The global interventional imaging market is projected to reach $16.93 billion by 2033 from $8.66 billion in 2022, growing at a CAGR of 6.71% during the forecast period 2023-2033.
The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032.
The Asia-Pacific surgical robotics market was valued at $1,637.6 million in 2022 and is expected to reach $8,068.7 million by the end of 2032, registering a CAGR of 17.29% during the forecast period 2022-2032.
The global advanced dental digital and robotics solutions market was valued at $3.82 billion in 2022 and is anticipated to reach $8.99 million by 2032, witnessing a CAGR of 9.15% during the forecast period 2023-2032.
The Asia-Pacific cell and gene therapy biomanufacturing market was valued at $1.96 billion in 2022 and is expected to reach $8.60 billion by the end of 2031, growing at a CAGR of 17.88% during the forecast period 2022-2031.
Asia-Pacific nucleic acid therapeutics CDMO market was valued at $0.97 billion in 2022 and is expected to reach $4.04 billion by 2033.
In 2022, the India emerging infectious disease diagnostics market was valued at $339.1 million and is expected to grow at a CAGR of 10.29% during the forecast period 2023-2033 to register a value of $982.7 million in 2033.
The global medical and surgical drainage system market was valued at $2,468.7 million in 2022 and is expected to reach $3,073.4 million by 2027, growing at a CAGR of 4.86% between 2023 and 2027.
The global biopsy devices market is projected to reach $11,869.4 million by 2027 from $5,852.8 million in 2022, growing at a CAGR of 15.15% during the forecast period 2023-2027.
The market is expected to grow at a CAGR of 7.07% during the forecast period 2023-2033 and attain a value of $4.79 billion by 2033.
The global wearable patches market was valued at $10,462.4 million in 2022 and is expected to reach $26,892.7 million by 2031, growing at a CAGR of 10.19% between 2023 and 2031.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global laboratory automation market was valued at $9.17 billion in 2022 and is anticipated to reach $24.84 billion by 2033, witnessing a CAGR of 9.57% during the forecast period 2023-2033.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
The global cell and gene therapy biomanufacturing CDMO market - focused on AAV was valued at $231.3 million in 2022 and is anticipated to reach $2,566.6 million by 2033, witnessing a CAGR of 24.61% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032.
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach $152.62 billion by 2033, growing at a CAGR of 5.41% between 2023 and 2033.
The global emerging infectious disease diagnostics market was valued at $19.56 billion in 2022 and is expected to reach $37.21 billion by 2033, growing at a CAGR of 6.19% between 2023 and 2033.
The global EV-based liquid biopsy market was valued at $78.22 million in 2022 and is anticipated to reach $455.53 million by 2032, witnessing a CAGR of 19.73% during the forecast period 2023-2032.
The global acute care syndromic testing market was valued at $3.14 billion in 2022 and is expected to reach $8.44 billion by 2033, growing at a CAGR of 9.43% between 2023 and 2033.
The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during the forecast period 2023-2033.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2023-2033.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global constrained peptide drugs market is expected to reach $17.38 billion in 2040 from $0.06 billion in 2024, growing at a CAGR of 38.94% during the forecast period 2025-2040.
The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033.
The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.
In 2022, the global functional genomics market was valued at $10.57 billion, and it is expected to reach $46.24 billion by 2033, growing at a CAGR of 14.04% during the forecast period 2023-2033.
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032.
A monthly review of how COVID-19 is impacting the diagnostics, therapeutics, and vaccines market. Overall, more than 225 treatment options were reported in April 2023.
The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global minimally invasive spine technologies market was valued at $3,180.9 million in 2022 and is anticipated to reach $9,406.5 million by 2032, witnessing a CAGR of 11.45% during the forecast period 2022-2032.
The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027.
The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.
The global deep venous disease treatment devices market was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032.
The global dry X-Ray film market was valued at $924.7 million in 2022 and is anticipated to reach $1,112.2 million by 2032, witnessing a CAGR of 1.86% during the forecast period 2022-2032.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032.
The global surgical robotics market was valued at $8,705.3 million in 2022 and is anticipated to reach $18,410.9 million by 2032, witnessing a CAGR of 7.78% during the forecast period 2022-2032.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The global medical X-Ray detectors market was valued at $2,167.0 million in 2022 and is anticipated to grow to $3,702.0 million by the end of 2032, at a projected CAGR of 5.50% during the forecast period 2022-2032.
The U.S. DTC wellness testing market is projected to reach $4,946.3 million by 2032 from $878.9 million in 2022, at a CAGR of 18.86% during the forecast period 2022-2032.
The U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is anticipated to grow to $3,989.9 million by the end of 2031, at a projected CAGR of 4.44% during the forecast period 2022-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The U.S. women health laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030.
The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032.
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.
The report focuses solely on the extensive stage small cell lung cancer treatment, which includes approved products as well as products under clinical development.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is forecasted to reach $29.28 billion by 2032.
The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032.
The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.
The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.
In 2021, the global NGS library preparation automation market was valued at $1,273.2 million, and it is expected to reach $3,803.3 million by 2029, growing at a CAGR of 14.85% during the forecast period 2022-2029.
The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.
The market size of MR imaging in neurosurgery was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031.
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
The global laparoscopy and endoscopy devices market was valued at $23,809.2 million in 2021 and is projected to reach $38,942.2 million by the end of 2031, growing at a CAGR of 4.94% during the forecast period 2022-2031.
In 2021, the global microbiome therapeutics market valued $306.3 million, and it is estimated to reach $3,204 million by 2032, registering a CAGR of 24.95% during the forecast period 2022-2032.
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032.
The global endoscopic imaging systems market was valued at $3,641.3 million in 2021 and is projected to reach $6,941.3 million by 2030.
The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 million in 2021, witnessing a CAGR of 12.04% during the forecast period 2022-2032.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The global next-generation oncology devices and solutions market was valued at $3,268.2 million in 2021 and is projected to reach $5,971.3 million by 2031.
The market size of digital biomanufacturing was valued at $15,768.9 million in 2021 and is anticipated to reach $55,564.9 million by the end of 2031, registering a CAGR of 13.12% during the forecast period 2022-2031.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The U.S. solid tumor testing market is projected to reach $18,287.6 million by 2032 from $9,498.8 million in 2021, at a CAGR of 6.19% during the forecast period 2022-2032.
The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
In 2021, the Middle East liquid biopsy market was valued at $43.7 million, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
In 2021, the Middle East precision medicine market was valued at $3,942.6 million, and it is expected to reach $8,620.0 million by 2032, growing at a CAGR of 7.37% during the forecast period 2022-2032.
In 2021, the global axial spondyloarthritis market was valued at $1,873.8, which is expected to reach $7,937.8 million in 2032 by witnessing a growing CAGR of 13.44% during the forecast period, 2022-2032.
The global blood and plasma components market is projected to reach $66.47 billion in 2031 from $39.58 billion in 2020, witnessing a CAGR of 4.90% during the forecast period 2021-2031.
The market size of digital biomarkers was valued at $1,808.3 million in 2021 and is anticipated to reach $16,174.0 million by the end of 2028, registering a CAGR of 36.06% during the forecast period 2022-2028.
In 2020, the global single cell bioinformatics software and services market was valued at $205.2 million, and it is expected to reach $634.8 million by 2031, growing at a CAGR of 10.89% during the forecast period 2021-2031.
The Europe infectious disease diagnostics market is projected to reach $7,900.4 million by 2031 from $1,394.3 million in 2020, at a CAGR of 16.48% during the forecast period 2021-2031.
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a CAGR of 17.08% during the forecast period 2021-2031.
The global operating room management solutions market was valued at $2,023.5 million in 2021 and is anticipated to reach $3,699.1 million by the end of 2031, registering a CAGR of 6.29% during the forecast period 2022-2031.
The report contains the analysis of variables such as recent trends, technological advancements, and international level initiatives across the globe influencing the adoption of acellular therapy.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to reach $130,132.1 million by the end of 2031, registering a CAGR of 13.96% during the forecast period 2022-2031.
The global radioligand therapy market is projected to reach $16,658.4 million by 2031, growing from $9,754.9 million in 2020, at a CAGR of 4.67% during the forecast period 2021-2031.
The report constitutes a strategical information and implementation for the plasma medicine market.
The global capillary electrophoresis market was valued at $318.3 million in 2020 and is expected to reach $586.9 million by 2031, growing at a CAGR of 5.66% during the forecast period 2021-2031.
In 2020, the global next-generation gynecological cancer diagnostics market was valued at $1,976.5 million, which is expected to reach $5,657.7 million by 2031, growing at a CAGR of 10.07% during the forecast period 2021-2031.
The global operating room (OR) integration systems market was valued at $11,763.6 million in 2021 and is projected to reach $21,546.1 million by the end of 2031.
The global oncology precision medicine market was valued at $45,174.2 million in 2020 and is expected to reach $1,28,891.6 million by 2031, growing at a CAGR of 10.05% during the forecast period 2021-2031.
The global dental radiography market was valued at $2,328.5 million in 2021 and is projected to reach $3,914.8 million by the end of 2031.
In 2020, the global hematological malignancies emerging therapeutics market was valued at $8,444.8 million, which is expected to reach $43,966.8 million in 2031.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global precision cardiology market is projected to reach $3,584.6 million by 2031 from $956.6 million in 2020, at a CAGR of 12.90% during the forecast period 2021-2031.
The global brain disease modalities and software market was valued at $13,055.7 million in 2021 and is projected to reach $21,867.6 million by the end of 2031.
The global brain imaging modalities market was valued at $12,334.2 million in 2021 and is projected to reach $20,209.2 million by the end of 2031.
The in-silico drug discovery market is projected to reach $10,409.9 million by 2031 from $1,619.6 million in 2020, at a CAGR of 18.47% in the forecast period of 2021-2031.
The neoantigen cancer vaccine market is projected to reach $1,988.5 million by 2031 from $35.5 million in 2024, at a compound annual growth rate (CAGR) of 77.73%.
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.
The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.
The global spine X-ray and computed tomography market was valued at $916.0 million in 2020 and is projected to reach $1,623.5 million by 2030.
The global ENT devices market was valued at $13,799.5 million in 2020 and is projected to reach $25,127.7 million by 2030.
The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.
The global medical grade tubing market was valued at $4,407.7 million in 2020 and is anticipated to reach $6,255.9 million by the end of 2030, witnessing a CAGR of 3.70% during the forecast period 2021-2030.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020 and is expected to reach $18,856.6 million by 2031, witnessing a CAGR of 29.60% during the forecast period 2021-2031.
In 2020, the global epigenetics market was valued at $2,434.6 million, and it is expected to reach $14,311.1 million by 2031, growing at a CAGR of 17.11% during the forecast period 2021-2031.
In 2020, the global cancer microbiome sequencing market was valued at $155.5 million, and it is expected to reach $1,216.2 million by 2031, growing at a CAGR of 20.01% during the forecast period 2021-2031.
The global next-generation biomanufacturing market is expected to grow at a CAGR of 14.85% during the forecast period 2021-2031 and is expected to reach a value of $85,201.2 million in 2031.
The global preimplantation genetic testing market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.
The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030.
The global molecular diagnostics market is projected to reach $24,228.0 million by 2031 from $10,914.6 million in 2020, at a CAGR of 7.38% during the forecast period 2021-2031.
The global surgical microscopes market was valued at $928.3 million in 2020 and is anticipated to reach $3,578.2 million by the end of 2031, growing at a CAGR of 13.3% during the forecast period 2021-2031.
The global interventional oncology devices market was valued at $2,429.2 million in 2020 and is projected to reach $7,861.1 million by the end of 2030.
The market for Europe hereditary genetic testing is predicted to grow at a CAGR of 13.34% during the forecast period 2021-2031.
The global transcriptomics market is projected to reach $33.68 billion by 2031 from $4.47 billion in 2020, at a CAGR of 20.11% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global pharmaceutical quality management software market report highlights that the market was valued at $472.6 million in 2020 and is expected to reach $3,717.7 million by the end of 2030.
The global imaging CRO market is expected to grow at a CAGR of 7.25% during the forecast period 2021-2031 and is expected to reach a value of $9,603.0 million in 2031.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031.
The global urgent care apps market was valued at $973.6 million in 2020 and is expected to reach $10,150.5 million by the end of 2030.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global AI-enabled X-Ray imaging solutions market was valued to be $66.0 million in 2020 and is anticipated to reach $639.7 million by 2031, witnessing a CAGR of 20.2% during the forecast period 2021-2031.
The global ophthalmic drug delivery devices market was valued at $295.4 million in 2020 and is anticipated to reach $537.8 million by the end of 2030, witnessing a CAGR of 6.17% during the forecast period 2021-2030.
The global advanced dermatology drug delivery devices market report highlights that the market was valued at $3,348.9 million in 2020 and is expected to reach $8,783.0 million by the end of 2030.
The global gel documentation systems market is projected to reach $411.1 million by 2030 from $275.4 million in 2020, at a CAGR of 4.04% during the forecast period 2021-2030.
The global liquid handling systems market was valued to be $3,210.2 million in 2020 and is expected to reach $7,128.1 million by 2031, witnessing a CAGR of 7.43% during the forecast period 2021-2031.
The global direct-to-consumer genetic testing market accounted for $1,155.9 million in 2020 and is expected to be $6,604.5 million by 2031.
The global non-invasive liquid biopsy market is projected to reach $9,470.3 million by 2031, growing from $1,096.9 million in 2020, at a CAGR of 20.38% during the forecast period 2021-2031.
The global industrial microbiological QC market is predicted to grow at a CAGR of 5.69% over the forecast period of 2021-2031.
The global electrocardiographs market report highlights that the market was valued at $4,394.1 million in 2020 and is expected to reach $9,826.8 million by the end of 2031.
The global nutrigenomics market is set to witness a CAGR of 17.26% during the forecast period 2021-2031.
The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030.
The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031.
The radiofrequency-based aesthetic devices report highlights that the market was valued at $1,052.6 million in 2020 and is expected to reach $3,204.1 million by the end of 2030.
The global market for aseptic pharma processing equipment is predicted to grow at a CAGR of 7.29% over the forecast period 2021-2030.
The nucleic acid isolation and purification market is projected to reach $5,010.3 million by 2031 from $2,304.7 million in 2020, at a CAGR of 7.20%.
The global long-read sequencing market is projected to reach $3,305.5 million by 2030 from $504.7 million in 2020, at a CAGR of 21.15% during the forecast period 2021-2030.
The global AI in operating room market was valued at $67.8 million in 2020 and is anticipated to reach $2,951.5 million by the end of 2030.
The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over the forecast period 2021-2031.
The global surgical instrument tracking devices market was valued at $354.3 million in 2020 and is anticipated to reach $868.2 million by 2031.
The global AI in neurology operating room market is projected to reach $692.8 million by 2030.
The global hemodynamic monitoring devices market was valued at $867.2 million in 2018 and is projected to reach $2,156.6 million by the end of 2030.
The global haptic feedback surgical environment market is expected to grow with a CAGR of 14.6% in terms of market value, during the forecast period 2021-2031.
The global market for mRNA vaccines and therapeutics for COVID-19 vaccines is predicted to decline at a CAGR of 13.50% over the forecast period of 2021-2025.
The global reproductive genetics market is predicted to grow at a CAGR of 12.38% over the forecast period 2021-2030.
The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020 and is anticipated to reach $21,079.7 million by 2031.
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is estimated to reach $16.77 billion by 2031.
The global emerging mental health devices and platforms market is projected to reach $18,717.5 million by the end of 2030, witnessing a CAGR of 24.69% during the forecast period 2021-2030.
The global hybrid operating room market was valued at $826.9 million in 2019 and is expected to reach $2,520.7 million by the end of 2030.
The global home healthcare market was valued at $130.18 billion in 2019 and is anticipated to grow to $214.98 billion by the end of 2025.
The global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030.
The global oncolytic virus therapies market is predicted to grow at a CAGR of 26.28% over the forecast period 2020-2030.
The global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030.
The global solid tumor testing market is projected to reach $40,660.6 million by 2030 from $22,504.1 million in 2020, at a CAGR of 6.09% during the forecast period 2020-2030.
The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030.
The global market for precision psychiatry is predicted to grow at a CAGR of 17.26% over the forecast period of 2021-2026.
The global digital respiratory devices market accounted for $13.1 million in 2019 and is expected to reach $405.1 million by 2030.
The global CDSS market was valued at $1.77 billion in 2019 and is expected to reach $3.74 billion by 2030.
Global Continuous Positive Airway Pressure Market to Reach $10,182.0 Million by 2026
The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030.
The global market for somatic genetic testing is predicted to grow at a CAGR of 9.30% over the forecast period of 2020-2030.
The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030.
The global wireless brain sensors market is set to witness a CAGR of 10.53% between 2021 and 2030.
The global rare disease diagnostics market has been currently witnessing a rapid growth and is expected to continue to grow at a CAGR of 8.57% during the forecast period, 2020-2030.
The global market for cell and gene therapy manufacturing QC is predicted to grow at a CAGR of 22.80% over the forecast period of 2020-2030.
The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031.
The global AI in healthcare market is anticipated to reach $35,892.2 million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030.
The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027.
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from $1,221.5 million in 2020, at a CAGR of 21.16% during the forecast period, 2020-2025.
The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030.
The global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030.
The radiation dose management market is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030.
The global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81% over the forecast period of 2021-2030.
The global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated to reach $2,399.9 million by 2030, growing at a CAGR of 12.2% during the forecast period 2020-2030.
The global single-use/disposable endoscopy market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period of 2020-2025.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global bioengineered skin substitutes market was valued at $1.31 billion in 2019 and is expected to reach $4.33 billion by 2030.
The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030.
The spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030.
The overall market was $5,681.1 million in FY2019, and it is expected to grow at a CAGR of 6.17% during the forecast period, 2021-2030.
The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030.
The global advanced balloon catheter market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030.
The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030.
The global minimally invasive neurosurgical systems market was valued at $419.8 million in 2019 and is anticipated to reach $1,217.4 million by 2030, growing at a CAGR of 11.9% during the forecast period 2020-2030.
The global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
The global femtech market was valued at $560.5 million in 2018 and is expected to be valued at $4,692.3 million, by the end of 2030.
The global non-oncology precision medicine market was valued at $41.1 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.03% and reach a value of $129.96 billion in 2030.
The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030.
The population sequencing market is projected to reach $64,047.6 million by 2030 from $21,730.4 million in 2020, at a CAGR of 11.41% during the forecast period, 2020-2030.
The global liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The global AI-enabled imaging modalities market was valued at $214.4 million in 2019 and is anticipated to reach $2,649.6 million by 2030.
The India telemedicine market was valued at Rs 380.22 crores in 2019, and is expected to be valued at Rs 1,765.56 crores, by the end of 2025.
The global market for PD-1/PD-L1 immunotherapy is predicted to grow at a CAGR of 10.72% over the forecast period of 2020-2030.
The global emerging sleep apnea devices and platforms market was estimated to be $4,882.2 million in FY2019, and it is expected to grow at a CAGR of 9.94% during the forecast period, 2021-2030.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
The global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025.
The global healthcare service robots market was valued to be $462.3 million in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $2.82 billion by 2025.
The global market for DNA damage response drugs is predicted to grow at a CAGR of 21.33% over the forecast period of 2020-2030.
The global telemedicine market was estimated to be $21.55 billion in 2019. It is anticipated to reach a value of $123 billion by the end of 2030.
The Global Point-of-Care Imaging Devices Market was valued to be $8.66 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $19.84 billion by 2030.
The global pediatric genetic testing market is expected to grow at a double-digit compound annual growth rate of 14.30% in the forecast period 2020-2030.
The global market size of the surgical robotics market is estimated to have been $4.71 billion in 2018 and is expected to reach $15.43 billion by 2029.
The global neurostimulation devices market is set to witness a CAGR of 8.87% during the period between 2021 and 2030.
The global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030.
The global market for infectious disease biomarker testing market is predicted to grow at a CAGR of 14.48% during the forecast period of 2020-2030.
The global next-generation surgical robotics market is expected to grow with a robust CAGR of 44.6% during the forecast period, 2020-2030.
The global skin microbiome modulators market was valued at $541.1 million in 2019 and is anticipated to grow over $2,971.6 million by 2030.
The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030.
The global DNA methylation market is predicted to grow at a CAGR of 15.70% over the forecast period of 2020-2030.
The global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.
The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic.
The global market for infectious disease rapid diagnostics is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period.
The U.S. solid tumor testing market is projected to reach $15,396.4 million by 2030 from $8,179.7 million in 2019, at a CAGR of 5.91% during the forecast period 2020-2030.
In 2019, the market size of the global tumor genomics market was valued at $8,131.0 million, and is expected to reach $16,287.2 million in 2028, registering a CAGR of 8.09% during the forecast period between 2020-2028.
Our healthcare experts are continuously analysing the impact of regulatory and industrial decisions on the global ventilator market. Moreover, the global market for ventilators is predicted to grow at an exponential CAGR of 176% by the end of 2020.
The global market for whole genome and exome sequencing is predicted to grow at a CAGR of 26.94% over the forecast period of 2019-2029.
Global Viral Vector and Plasmid Manufacturing Market to Reach $5.86 Billion by 2030.
The global tissue imaging market was valued to be $14.42 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $37.44 billion by 2030.
The global companion diagnostics market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030.
The global non-invasive drug delivery devices market was valued at $548.5 million in 2018 and is anticipated to reach $2,354.4 million by 2025.
The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $1,072 million in 2018, and it was expected to grow at a CAGR of 7.1% in the pre-COVID scenario by the end of 2026.
The Global Medical Devices Testing Services Market Report by BIS Research projects the market to grow at a significant CAGR of 10.81% during the forecast period, 2019-2029.
The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029.
Global clinical biomarkers market analysis by BIS Research projects the market to grow at a significant CAGR of 10.07% during the forecast period, 2019-2029.
The Global Human Microbiome Sequencing Market Report by BIS Research projects the market to grow at a significant CAGR of 19.44% during the forecast period, 2019-2029.
The Global Minimally Invasive Surgical Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.51% during the forecast period, 2020-2030.
Global OR Communication Market by BIS Research projects the market to grow at a significant CAGR of 7.71% during the forecast period 2019-2025.
The Global AI-Enabled Drug Discovery and Clinical Trials Market Report by BIS Research projects the market to grow at a significant CAGR of 24.88% during the forecast period from 2019 to 2030.
The global virtual diagnostics market industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.52% during the forecast period, 2019-2030.
The Global Digital Biomarkers Market Report by BIS Research projects the market to grow at a significant CAGR of 40.39% during the forecast period from 2019 to 2025.
The RNA sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 14.21% during the forecast period, 2019-2028.
The U.S. hematologic malignancies market analysis by BIS Research projects the market to grow at a significant CAGR of 14.60% during the forecast period, 2019-2025.
The minimally invasive biopsy technologies market industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The single cell sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029.
The Global Robotic Surgery Consumables Market Report by BIS Research projects the market to grow at a significant CAGR of 11.37% during the forecast period, 2020-2030.
The in-silico drug discovery industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029.
The Global Electronic Skin Patches industry analysis by BIS Research projects the market to grow at a significant CAGR of 17.22% during the forecast period, 2019-2024.
Global Advanced Power Solutions for Implantable and Wearable Medical Devices Market by BIS Research projects the market to grow at a significant CAGR of 6.26% during the forecast period 2019-2029.
The global oncology informatics market to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025.
The global neoantigen cancer vaccine market to grow at a significant CAGR of 34.69% during the forecast period, 2023-2030.
The global microfluidics market to grow at a significant CAGR of 13.73% during the forecast period, 2019-2029.
The global recombinant cell culture supplements market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029.
The global roboticare market was valued to be $408.6 million in 2018 and is projected to grow at a CAGR of 18.27% from 2019 to 2029.
The global patient monitoring solutions market to grow at a significant CAGR of 6.50% during the forecast period from 2019 to 2028.
The global next-generation visualization and navigation systems market was valued at $1.08 billion in 2018 and is anticipated to reach $4.34 billion by 2029, growing at a CAGR of 13.08% during the forecast period 2019-2029.
The global photoacoustic imaging market to grow at a significant CAGR of 28.88% during the forecast period, 2019-2029.
The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $XX billion by 2029.
The Global Interoperability Solutions in Healthcare Market Report by BIS Research projects the market to grow at a significant CAGR of 5.9% during the forecast period from 2019 to 2025.
The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.
The global molecular forensics market has been currently witnessing a rapid growth and is expected to continue to grow with a CAGR of 9.09% during the forecast period, 2019-2029.
The global holographic imaging market is expected to register a CAGR of 35.9% during the forecast period 2019-2029.
Human Microbiome Therapeutics Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 33.00% during the forecast period 2019-2029.
The global bioelectric medicine market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025.
Radiation Therapy Quality Assurance Phantoms Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 4.59% during the forecast period 2019-2024.
The Global Patient Engagement Solutions Market report by BIS Research projects the market to grow at a significant CAGR of 14.09% during the forecast period from 2019 to 2028.
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025.
The global blockchain in genomic market analysis by BIS Research projects the market to grow at a significant CAGR of 66.42% during the forecast period, 2019-2029.
The advanced prosthetics and exoskeleton market was valued to be $2.11 Billion in 2018 and is estimated to reach a market value of $3.82 Billion by 2024 at a CAGR of 10.42% from 2019 to 2024.
The global surgical robotics market is anticipated to grow at a robust CAGR of 10.7% during the forecast period 2019-2029.
The AI-enabled medical imaging solutions market to grow at a significant CAGR of 30.95% during the forecast period, 2019-2029.
The global molecular diagnostic point of care industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.14% during the forecast period, 2019-2029.
The global radiation dose management industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.22% during the forecast period, 2019-2025.
The global robotic surgical simulation systems market was valued to be $276.5 million in the year 2018 and is anticipated to witness an impressive double-digit growth rate, to reach $1.03 Billion by 2024.
The Global Chatbots in Healthcare Market Report by BIS Research projects the market to grow at a significant CAGR of 26.29% during the forecast period from 2019 to 2029.
The Global Operating Room Management Solutions Market Report by BIS Research projects the market to grow at a significant CAGR of 6.4% during the forecast period from 2019 to 2029.
The global advanced wound care market, by products, was valued to be $8,904.6 million in 2018 and is estimated to reach a market value of $11,059.3 million by 2024.
The global stem cell therapy market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.
The global NGS based monitoring and diagnostic test market to grow at a significant CAGR of 18.08% during the forecast period, 2019-2028.
The global mobile C-Arm market was valued to be $1.03 billion in 2018 and is expected to reach $1.85 billion by 2029, witnessing a CAGR of 5.16% in the forecast period 2019-2029.
The global molecular imaging market market was valued at approximately $6.84 billion in 2018 and is anticipated to reach $11.13 billion by 2028.
The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression.
In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029..
The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast period, 2019-2025.
The China Precision Medicine Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2029.
The Global Spinal Fusion Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 5.40% during the forecast period of 2019 to 2028.
The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is anticipated to reach $2.69 billion by 2023.
The Global Oligonucleotide Synthesis Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 11.02% during the forecast period from 2019 to 2029.
The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.
The Global Clinical Decision Support Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 8.3% during the forecast period from 2019 to 2028.
The global digital respiratory devices market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
The Global OR Visualization Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.52% during the forecast period from 2019 to 2025.
The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.
The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.
The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.
The global hearing aids market was estimated at $8.37 billion in 2018 and is anticipated to reach $16.34 billion by 2028.
The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.
The global neurostimulation devices market has been witnessing annual growth rate of approximately 13.14% in past three years (2015-2018), and the market is expected to continue to grow with the CAGR of 9.23% during the forecast period, 2019-2024.
The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.
In 2018, the global next-generation sequencing market was valued at $4.93 billion and is anticipated to grow at a CAGR of 13.18% in the forecast period 2019-2024.
The global phototherapy devices market was valued at approximately $682.3 million in 2018 and is anticipated to reach $1.07 billion by 2028.
The global Augmented Reality and Virtual Reality market has been witnessing a steady growth. The market is expected to grow with a double digit CAGR of 23.13% during the forecast period, 2019-2025.
The global healthcare IoT security market is expected to continue to grow with a double digit CAGR of 41.38% during the forecast period 2019-2028.
The global OR integration systems market is expected to continue to grow with a single digit CAGR of 7.1% during the forecast period, 2019-2025.
The Latin America cell culture market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.20% during the forecast period, 2018-2025.
The global anti-aging devices market was estimated at $6.37 billion in 2017 and is anticipated to reach $15.77 billion by 2028.
The global industrial microbiological QC market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.
The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.
The Latin America liquid biopsy market is anticipated to reach $70.9 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.
The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated to reach $170.70 billion by 2028.
The global teleradiology services market was valued $2.63 billion in 2017 and is expected to grow at a CAGR of 15.06% during the forecast period between 2018 and 2026.
The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.
The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.
The global healthcare robotics market was estimated at $5.40 billion in 2017 and is anticipated to reach $11.44 billion by 2023.
The global portable imaging solutions market is expected to reach $5.74 billion by 2028.
The global artificial organs market was estimated at $1.6 billion in 2017 and is anticipated to reach $5.37 billion by 2023.
The global mammography system market is expected to reach $3.51 billion by 2028.
The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.
The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.
The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.
The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.
As of 2017, the global joint reconstruction market was estimated to be $16.82 billion and is expected to reach a value of $26.81 billion by the end of 2025, growing with a double digit CAGR during the forecast period.
The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.
The global surgical robotics market is expected to reach $11.65 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services.
As of 2019, the global NGS informatics and clinical genomics market was estimated to be approximately $957.0 million and is expected to reach a value of an estimated $5,016.0 million by the end of 2028.
The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025.
The global image guided interventions market is expected to reach $6,509.3 million by 2028.
The global interventional cardiology market was estimated at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027.
The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.
The global CDx market is expected to continue to grow with a double digit CAGR of 21.38% during the forecast period, 2018-2025.
The total addressable market size for laparoscopic and endoscopic devices market was $17.78 billion in the year 2016 and is expected to reach about $27.92 billion by the end of 2025.
In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach ~$70 billion by 2020 with effective implementation of several novel technologies.
The global ambulatory device market is expected to reach $17.55 billion by 2028.
The global orthodontics market is expected to reach $7.47 billion by 2025.
The global radiofrequency-based devices market for lower back pain is expected to reach $444.4 million by 2026.
Overall in 2017 the global minimally invasive surgical systems market value was estimated at $23.95 billion, which is estimated to grow over $40.52 billion by 2025.
The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is anticipated to reach $98.24 billion by 2025.
The global bioprinting market is expected to reach $4.70 billion by 2025 from $1.07 billion in 2016, at the CAGR of 15.2% during the forecast period, 2018-2025.
The global cell free DNA isolation and extraction market was valued at $81.7 million in 2016, and is anticipated to reach $442.8 million by 2026.
The global medical lighting technologies market is expected to account for $2.76 billion by 2026.
The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is estimated to grow over $37.47 billion by 2025.
The global biosensors market was valued at $1.46 billion in 2017 and is anticipated to reach $3.90 billion in 2027, registering a CAGR of 10.34% in the forecast period 2018-2027..
The blockchain in healthcare market is estimated to amount to $176.8 million in 2018 and is expected to grow at a CAGR of 63.85% from 2018 to 2025.
The global CRISPR technology market is expected to reach $10.55 billion by 2027.
The global electrosurgical devices market was estimated at $2.64 billion in 2016 and is anticipated to reach $4.33 billion by 2023.
The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.
The global big data in healthcare market was estimated to be worth $14.25 billion in 2017, and is expected to grow over $68.75 billion by 2025.
The global medical assistive technologies market is expected to grow over $24.41 Billion by 2025.
The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is estimated to grow over $14.7 billion by 2025.
The global mobile medical apps market was estimated at $1.40 billion in 2016, and is anticipated to reach $11.22 billion by 2025.
The global laboratory automation systems market was estimated at $5.05 billion in 2016 and is anticipated to reach $9.55 billion by 2026.
The global surgical robotics market is expected to reach $12.60 billion by 2025.
The global regenerative medicines market is expected to reach $50.55 billion by 2025.
Medical image analysis software application perform a vital role after the image has been acquired in digital form is the analysis of the acquired image to extract medically or clinically relevant information for diagnosis & treatment planning. It can be either for a general purpose or designed for any specific medical application area.
The global CDSS market is expected to reach a value $10.82 billion by the end of 2025 and is driven by the increasing demand for IT solutions to effectively reduce the healthcare costs. The rising number of chronic diseases and technical advancements in big data such as use of machine learning and artificial intelligence (AI) are further propelling the growth of the market.
The global precision medicine market was dominated by the oncology segment in 2016. The oncology market is expected to grow with a CAGR of 10.4% from 2017 to 2026. The rise in the number of cancer cases has significantly increased the global economic burden and is estimated to be approximately $4 trillion in 2025.
(Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis, Funding Scenario, Trend Analysis, and Competitive Landscape)
The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025.
The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.
The artificial intelligence market in healthcare sector is estimated to reach $XX million by 2025 at a CAGR of XX% through the forecast period. This growth in the artificial intelligence market in healthcare sector is attributed to the increasing need for driving huge amount of complex data which can be achieved with the usage of artificial intelligence.
The global population health management solution market can be segmented on the basis of type of component into software and services. The software segment is the leading segment of the PHM market considering the huge demand for PHM tools and platforms to collect, analyse and interpret clinical data to enable improved patient outcomes.
The global cancer imaging systems is expected to reach $11 billion by 2025.
The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.
The global high acuity information solutions market is expected to reach $13.69 billion by the end of 2025 growing at a CAGR of 8% during the forecast period, 2017-2025.
The global next generation implants market is estimated to grow over $3.9 billion by 2023. On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023. On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants.
The global healthcare RFID market is anticipated to reach $4.1 billion by 2021 growing at a CAGR of 21.64% during the forecast period between 2017-2021. The growth in RFID in healthcare market over the period 2017-2021 is expected to be primarily supplemented by factors such as increasing need of patient monitoring due to increasing geriatric population, advancement of product development and incr
The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is estimated to grow over $22.7 billion by 2025. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global biomaterials market was valued at $72.36 billion in 2016 and is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021.
The global Orthopedics devices market is expected to reach $61 billion by 2023. A growing geriatric population and increasing demand for non-invasive treatments are boosting the market growth.
The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) applica
The global pacemakers and ICDs market are expected to grow at a CAGR of 4.6% and 4.8% from 2017 to 2023. The factors includes revenue growth by dual chamber ICDs and Leadless Pacemakers as well as MRI Compatible ICD devices.
The global Wound Cleansers Product market is growing at a CAGR of 5.4%. On the basis of wound type, the market has been segmented into acute wounds, non-acute surgical wounds, chronic wounds and others.
The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.
The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.
North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).
IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare spending globally. The category’s rate of growth is accelerating due to a number of key macro forces, such as demand from emerging economies, aging population, evolving clinician attitudes, and a much needed push towards theranostics and personalized medicine.
The global incidence rate of jet-lag is still unknown, but it impacts a high percentage of approximately 30 million plus jet travelers who leave the U.S. yearly for destinations that cross five or more time zones. Globally, jet lag affects more than 100 million people annually.
The global emerging cancer diagnostics market is expected to grow at a CAGR of 13.45% from 2016 to 2023 and reach a figure of $6.34 billion by 2023. The advancements in technology, adoption of biomarker tests, and increasing cancer incidence rate are some of the major driving factors for this market. The global emerging cancer diagnostics market has been classified on the basis of test type, appli
The global advanced wound care market is expected to reach $10,940.7 million in 2022, growing at a CAGR of 5.0% from 2016 to 2022. Advanced wound care dressings accounted for the largest market share of the advanced wound care technology market in 2015.
The global CGM(Continuous Glucose Monitoring) Systems market has been identified as one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory framework and the intense competitive rivalry among a plethora of public companies.
In 2015, the global 3D bio printer market generated total market size of $148.5 million and the market is estimated to multiply extensively and reach $581.8 million by 2022. The main reason for this increase is the growing need of 3D bioprinting technology in pharmaceutical industry, universities, research labs, hospitals, clinics and other essential areas.
The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.
The pharmacovigilance market is expected to reach a market size of $8.23 billion by 2022. Stringent compliance with drug safety regulations and increasing incidents of ADRs are acting as key drivers for the growth of this market.
The global prenatal testing market is growing at a CAGR of 28.85% from 2016 to 2022 and is estimated to grow over $7.2 billion by 2022. Prenatal tests are classified into two main categories viz. Screening and Diagnostics. Both screening and diagnostics have witnessed an exponential growth in procuring treatments for disorders which increased in the past two decades.
The Healthcare IOT Security market is expected to grow at a CAGR 39.44% during the forecast period because of increased connectivity of smart IOT devices with the healthcare organizations for better health management and government support and acknowledgement for IOT Security in the healthcare sector.
Advancement and innovation of new healthcare technologies such as next generation sequencing, high throughput screening (HTS), and Digital PCR are developing the platform for the growth of Pharmacogenomics (PGx) market. The global PGx market is expected to grow over $14.85 billion by 2022.
Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare industry which has shown a tremendous level of progress in the last few years. The growth of prenatal and newborn genetic testing market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, and advancement of healthcare technologies. The global prena
The study involves segmentation of 3D printing healthcare industry based on technology, end-point application, various applicable materials, and geography. The market potential of 3D printing in healthcare industry has been analyzed on the basis of aforementioned segments.
The healthcare industry is in a period of rapid change. Advancements in the fields of genetics, biomedical, and information technology are paving a way towards effective personalized treatments in accordance to the individual characteristics of the patients. Exploiting these opportunities requires effective usage of Big Data.
With the advancement of drug delivery technologies and blood glucose diagnostic devices, the Diabetic Care market has emerged as a fast developing sector in healthcare. The overall market growth is gaining speed as large number of government initiatives and research & development programs have been launched in the recent years.
Precision medicine is becoming one of the most modernized trends in the healthcare industry showing an incredible growth in the recent years. According to the report put forward by the market research experts of BIS Research, the global precision medicine market is expected to grow over $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022.
The mHealth services dominated the market in 2014 and are expected to grow over $55.63 billion by the end of the forecast period due to the increasing usage of mHealth solutions by healthcare providers and pharmaceutical companies along with end users (patients). However, device segment is expected to grow in near future with a high CAGR of 38.02%, from 2015 to 2022.
The U.S. Cervical cancer laboratory testing maket refers to diagnostic procedures used to detect abnormalities in the cervix that may lead to cervical cancer.
Genetic screening testing for preventive health market involves analyzing an individual’s genetic makeup to predict the likelihood of developing certain diseases or conditions in the future.
Genetic screening testing for reproductive health refers to a set of medical tests designed to assess the genetic makeup of individuals before or during pregnancy.
The Point-of-Care (PoC) Cell and Gene Therapy Manufacturing Market is projected to grow significantly driven by key advancements in automation, decentralized manufacturing, and personalized medicine.
The north america immunoassay market is driven by advancements in healthcare, increasing disease prevalence, and a shift toward precision diagnostics.
The in-vitro diagnostics (IVD) market in North America is growing due to rising chronic diseases, technological advancements, and a shift toward personalized medicine.
This report provides an in-depth market analysis, covering segmentation by application, technology, product, end-user, and geography.
The global market for CRISPR gene diagnostics is growing robustly. In 2025, the market size is projected around USD 3 billion, and it is expected to double to approximately USD 7 billion by 2030.
The Europe liquid biopsy market, valued at $1.24 billion in 2024, is expected to reach $5.58 billion by 2033, exhibiting a robust CAGR of 18.18% during the forecast period 2024-2033.
The Europe Hematologic Malignancies Testing Market is expanding rapidly due to the increasing prevalence of blood cancers such as leukemia, lymphoma, and multiple myeloma. Developments in diagnostic technologies, including flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and immunohistochemistry, are improving prognosis, treatment planning, and early detection.
The Asia-Pacific Companion Diagnostics Market was valued at $733.7 million in 2023 and is expected to reach $2,849.7 million by 2033, growing at a CAGR of 14.53% during the forecast period of 2023-2033.
Softgel capsules are a preferred dosage form for liquid or semi-solid substances, offering several benefits including ease of swallowing, precise dosing, improved bioavailability, and protection of sensitive ingredients from environmental degradation.
Whole genome sequencing refers to the DNA sequencing of the entire genome, both coding and non-coding regions to detect inherited disease and track disease outbreaks.
Whole-exome sequencing is utilized to examine the protein-coding regions of the genome, aiming to reveal genetic factors that influence disease and population health.
A blood pressure cuff is a medical device used to measure blood pressure. The cuff is placed around the upper arm and inflated to temporarily halt blood flow in the artery.
The global specialty excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations.
The empty capsules are primarily used for encapsulating powdered and granular substances. These capsules, typically made from gelatin or vegetable-based materials, offer an effective delivery system for medications, vitamins, and other supplements.
The global excipients market for topical pharmaceuticals is growing, driven by demand for effective dermatological treatments and cosmeceuticals.
The liquid-filled capsules market is rapidly evolving, characterized by the growing preference for innovative delivery systems in the pharmaceutical and nutraceutical sectors.
The Hybrid Medicine market is quickly gaining traction as healthcare providers increasingly look to combine conventional treatments with alternative therapies for more comprehensive patient care.
The Cell Line Characterization Market Report provides a comprehensive analysis of the global market, offering valuable insights into the trends, and future prospects of the industry.
The global 3D image capture in wound care market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities within the wound care sector.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The global shadowless surgical lights market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities within the surgical lighting sector.
This comprehensive report provides an in-depth analysis of the global implantable microchip market. It offers a detailed examination of the market dynamics, including drivers, restraints, opportunities, and challenges that influence the growth trajectory of the industry.
The Asia-Pacific acute care syndromic testing market was valued at $0.78 billion in 2023 and is expected to reach $2.20 billion by 2033, growing at a CAGR of 10.97% between 2023 and 2033.
The Europe next-generation breast cancer diagnostic and screening market was valued at $0.84 billion in 2023 and is expected to reach $2.57 billion by the end of 2032, registering a CAGR of 13.20% during the forecast period 2023-2032.
The Asia-Pacific scar management market is expected to reach $363.4 million by 2030 from $209.8 million in 2022 at a CAGR of 7.14% during the forecast period 2023-2030.
The global ultrasound systems market report provides a comprehensive analysis of the industry, offering insights into market dynamics, trends, and growth prospects.
The global SPECT market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The Antibody Hit Generation and Screening Market report covers key segments, competitive landscape, and emerging technologies, offering stakeholders a holistic view of the global market.
Explore the Global Dialysis Equipment Market, driven by rising kidney disease rates & technological advancements, offering improved patient care and treatment efficiency.
Cardiac marker tests offer valuable information to healthcare providers, facilitating rapid diagnosis and risk stratification of cardiac events.
Incubator Systems Market explores market based on segmentations such as by technology, by end user, and by product type, the impact of macroeconomic factors market growth
The healthcare robotics market has undergone a gradual, however, considerable development over the last few decades.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
The global cell free DNA isolation and extraction market was valued at $81.7 million in 2016, and is anticipated to reach $442.8 million by 2026.
Overall in 2017 the global minimally invasive surgical systems market value was estimated at $23.95 billion, which is estimated to grow over $40.52 billion by 2025.
The total addressable market size for laparoscopic and endoscopic devices market was $17.78 billion in the year 2016 and is expected to reach about $27.92 billion by the end of 2025.
The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.
The global CDx market is expected to continue to grow with a double digit CAGR of 21.38% during the forecast period, 2018-2025.
The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.
The global surgical robotics market is expected to reach $11.65 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services.
The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.
The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.
The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.
The global industrial microbiological QC market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.
The global OR integration systems market is expected to continue to grow with a single digit CAGR of 7.1% during the forecast period, 2019-2025.
The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.
The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
The global digital respiratory devices market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.
The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.
The Global Clinical Decision Support Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 8.3% during the forecast period from 2019 to 2028.
The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast period, 2019-2025.
The AI-enabled medical imaging solutions market to grow at a significant CAGR of 30.95% during the forecast period, 2019-2029.
The Global Operating Room Management Solutions Market Report by BIS Research projects the market to grow at a significant CAGR of 6.4% during the forecast period from 2019 to 2029.
The global robotic surgical simulation systems market was valued to be $276.5 million in the year 2018 and is anticipated to witness an impressive double-digit growth rate, to reach $1.03 Billion by 2024.
The global surgical robotics market is anticipated to grow at a robust CAGR of 10.7% during the forecast period 2019-2029.
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025.
The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.
The global recombinant cell culture supplements market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029.
The global neoantigen cancer vaccine market to grow at a significant CAGR of 34.69% during the forecast period, 2023-2030.
The in-silico drug discovery industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029.
The Global Robotic Surgery Consumables Market Report by BIS Research projects the market to grow at a significant CAGR of 11.37% during the forecast period, 2020-2030.
The Global Minimally Invasive Surgical Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.51% during the forecast period, 2020-2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The global ENT devices market was valued at $13,799.5 million in 2020 and is projected to reach $25,127.7 million by 2030.
The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029.
Global clinical biomarkers market analysis by BIS Research projects the market to grow at a significant CAGR of 10.07% during the forecast period, 2019-2029.
The global market for whole genome and exome sequencing is predicted to grow at a CAGR of 26.94% over the forecast period of 2019-2029.
The U.S. solid tumor testing market is projected to reach $15,396.4 million by 2030 from $8,179.7 million in 2019, at a CAGR of 5.91% during the forecast period 2020-2030.
The global companion diagnostics market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period.
The global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.
The market is predicted to grow at a CAGR of 13.12% over the forecast period of 2020-2030.
The global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The global liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030.
The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030.
The spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period of 2020-2025.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030.
The radiation dose management market is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030.
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from $1,221.5 million in 2020, at a CAGR of 21.16% during the forecast period, 2020-2025.
The global rare disease diagnostics market has been currently witnessing a rapid growth and is expected to continue to grow at a CAGR of 8.57% during the forecast period, 2020-2030.
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is estimated to reach $16.77 billion by 2031.
The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over the forecast period 2021-2031.
The global AI in operating room market was valued at $67.8 million in 2020 and is anticipated to reach $2,951.5 million by the end of 2030.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
I would like to extend our appreciation for your support in finalizing the report according to our precise needs and prerequisites. I am also impressed by the timely completion of all aspects of dealing with us as your esteemed client. I look forward to continue our professional relations in the future.
Manager-Strategy & Business DevelopmentICL Industrial Products
“I found the content quite interesting and insightful. It has provided us with some important information”
Strategic Insights COE ManagerJapan Tobacco International
I appreciate the extra effort that team BIS took to cater to our specific requirements, moreover, their response time and adaptability is at par with my expectation.
CEO & ChairmanTEKNA Plasma Systems
“BIS research has been a great support to our strategic investigation in the field of thermoplastic composite. BIS did manage to bring together a clear picture on a global level, supported by examples and references and they delivered an accurate evaluation of the current market size and potential in the coming years in line with our expectations. I warmly recommend them.”
VPFuture Business and Innovation
Trusted by the world's largest business
